Featured
ALBORADA Drug Discovery Institute identifies advanced Huntington’s leads using...
BioAscent’s unique on-demand compound library, Compound Cloud, has been used by the ALBORADA Drug Discovery Institute for virtual screening and to progress promising leads against a novel Huntington’s disease target.